HAP Trading, LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 46 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
HAP Trading, LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$4,000
-99.5%
10,900
-78.9%
0.00%
-100.0%
Q3 2021$729,000
+1.8%
51,600
-59.2%
0.02%
+9.1%
Q2 2021$716,000
+326.2%
126,500
+75.0%
0.02%
+144.4%
Q1 2021$168,000
+3260.0%
72,300
+464.8%
0.01%
Q4 2020$5,00012,8000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,355,925$2,955,9172.56%
Susquehanna International Group Ltd. 113,526$247,4870.14%
XTX Topco Ltd 151,620$330,5320.07%
Corsair Capital Management 47,256$103,0180.04%
Diametric Capital, LP 14,314$31,2050.02%
Draper Asset Management, LLC 5,320$11,5980.02%
ETF MANAGERS GROUP, LLC 68,940$150,2890.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$12,2670.00%
TWO SIGMA INVESTMENTS, LP 506,255$1,103,6360.00%
Apollon Wealth Management, LLC 20,000$43,6000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders